ethyl (3S,4R)-4-[(5-chlorothiophene-2-carbonyl)amino]pyrrolidine-3-carboxylate | 913942-16-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: ethyl (3S,4R)-4-[(5-chlorothiophene-2-carbonyl)amino]pyrrolidine-3-carboxylate
• CAS: 913942-16-2
• 化学式: C₁₂H₁₅ClN₂O₃S
• 分子量: 302.782
• InChiKey: WTLSTMNODBERJY-YUMQZZPRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  95.7
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-bromo-[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenyl]-acetamide 、 ethyl (3S,4R)-4-[(5-chlorothiophene-2-carbonyl)amino]pyrrolidine-3-carboxylate 在 potassium carbonate 作用下， 以 乙腈 为溶剂， 生成 (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl-carbamoyl]-methyl}-pyrrolidine-3-carboxylic acid ethyl ester
  参考文献：
  名称：

  Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit

  摘要：

  Starting from a hit identified by focused screening, 3-aminopyrrolidine factor Xa inhibitors were designed. The binding mode as determined by X-ray structural analysis as well as the pharmacokinetic behaviour of selected compounds is discussed. (C) 2009 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2008.12.025
• 作为产物：
  描述：

  (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 在 盐酸 作用下， 以 1,4-二氧六环 为溶剂， 生成 ethyl (3S,4R)-4-[(5-chlorothiophene-2-carbonyl)amino]pyrrolidine-3-carboxylate
  参考文献：
  名称：

  Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit

  摘要：

  Starting from a hit identified by focused screening, 3-aminopyrrolidine factor Xa inhibitors were designed. The binding mode as determined by X-ray structural analysis as well as the pharmacokinetic behaviour of selected compounds is discussed. (C) 2009 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2008.12.025

文献信息

• Cyclic amines
  申请人：Zbinden Groebke Katrin

  公开号：US20060247238A1

  公开（公告）日：2006-11-02

  The invention is concerned with cyclic amines of formula (I) wherein X 1 to X 3 , Y 1 to Y 3 , R 1′ , R 1″ and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit coagulation factor Xa and can be used as medicaments and for treating diseases associated with coagulation factor Xa.

  这项发明涉及公式(I)中的环氨基化合物，其中X1至X3，Y1至Y3，R1'，R1"和n如描述和索赔中定义的那样，以及其生理上可接受的盐。这些化合物抑制凝血因子Xa，并可用作药物治疗与凝血因子Xa相关的疾病。
• NOVEL CYCLIC AMINES
  申请人：F. Hoffmann-La Roche AG

  公开号：EP1877404A2

  公开（公告）日：2008-01-16
• US7820699B2
  申请人：——

  公开号：US7820699B2

  公开（公告）日：2010-10-26
• [EN] NOVEL CYCLIC AMINES<br/>[FR] NOUVELLES AMINES CYCLIQUES
  申请人：HOFFMANN LA ROCHE

  公开号：WO2006114401A2

  公开（公告）日：2006-11-02

  [EN] The invention is concerned with novel cyclic amines of formula (I) wherein X¹ to X³, Y¹ to Y³, R^1' , R^1'' and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
  [FR] L'invention concerne de nouvelles amines cycliques ayant la formule (I) dans laquelle X¹ à X³, Y¹ à Y³, R^1', R^1'' et n sont définis dans la description et les revendications ainsi que leurs sels physiologiquement acceptables. Ces composés inhibent le facteur de coagulation Xa et peuvent s'utiliser en tant que médicaments.